Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
28.75    0.00 (0.00%)
Bid:
28.50
Ask:
29.00
Spread: 0.50 (1.754%)
Market Cap: £121.51m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Director Shareholding

23 Jul 2010 07:00

RNS Number : 8013P
Merchant Securities Group PLC
23 July 2010
 



AIM: MERC

 

MERCHANT SECURITIES GROUP PLC

("Merchant Securities" or "the Company")

 

Director Shareholdings

 

Merchant Securities, the financial services group, announces that the Board today approved the grant of options over the Company's ordinary shares, under the terms of the Merchant Securities Group plc Executive option scheme, and that the trustees of the Merchant Employee Benefit Trust ("EBT") have allocated a proportion of the ordinary shares of 1p each in the Company ("Shares") held by the EBT to Directors of the Company.

 

The Board has granted options over 550,000 ordinary shares ("Options") to Patrick Claridge, Chief Executive of the Company. The Options have been granted at 30p per share, representing a premium of 25 per cent. over the closing middle-market price on 22 July 2010. The Options vest as to one third on the first anniversary of the date of grant, one third on the second anniversary of the date of grant and the balance on the third anniversary of the date of grant. Upon vesting, the Options are exercisable until 22 July 2020.

 

Following the grant of these Options, Mr Claridge holds options over the following ordinary shares in the Company:

 

Number of options

Exercise Price

Exercise Period

550,000

30p

From 23 July 2011 until 22 July 2020

562,514

10p

From 9 September 2009 until 8 September 2019

 

In addition, Mr Claridge and Mr Foster-Powell, Chief Financial Officer of the Company, have been allocated 87,500 and 18,750 Shares, respectively, as part of the deferred equity element of an incentive award made by the Remuneration Committee, currently held by the EBT, relating to the financial performance of the Company in the year ended 31 March 2010. These Shares will be held by the Trustees of the EBT as nominee and will transfer on the second anniversary of the date of allocation.

 

Following the allocation by the EBT, Mr Claridge and Mr John Foster-Powell will be beneficially interested in 2,735,528 and 618,750 ordinary shares of 1p each respectively, equivalent to 5.83 per cent. and 1.32 per cent. of the issued share capital of the Company, respectively.

 

 

For further information please contact:

 

   

Merchant Securities Group plc

Patrick Claridge, Chief Executive

 

  T: 020 7628 2200
Arden Partners plc

Richard Day

Matthew Armitt

 

  T: 020 7614 5917
Biddicks

Katie Tzouliadis

Sophie Lane

 

  T: 020 7448 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSRTMRTMBBTBPM
Date   Source Headline
29th Jul 20192:24 pmRNSNotification of Major Holdings
26th Jul 20197:00 amRNSPublication of Annual Report
8th Jul 20197:00 amRNSPreliminary Results
5th Jul 201910:00 amRNSChange of Name
2nd Jul 20197:00 amRNSDirectorate Change
21st May 20197:00 amRNS£2.4million syndicated investment into Medherant
15th May 20197:00 amRNS£2.0million syndicated investment into Locate Bio
14th May 20197:06 amRNSConcepta PLC confirms first myLotus® pregnancies
2nd May 20197:00 amRNSNotice of Preliminary Results
11th Apr 20199:41 amRNSPDMR Dealing
10th Apr 20197:00 amRNSDirector/ PDMR Dealings
28th Mar 20197:00 amRNS£6.5m syndicated investment into Oxford Genetics
18th Mar 20194:23 pmRNSPDMR / Director Dealings
15th Mar 20191:19 pmRNSPDMR / Director Dealings
12th Mar 20197:06 amRNSPortfolio company Concepta secures partnership
28th Feb 20197:00 amRNSPortfolio company announces six licensing deals
20th Feb 20197:00 amRNSSoftware & the Internet Portfolio Update
5th Feb 20197:00 amRNSAppointment of NOMAD
3rd Dec 20187:00 amRNSHalf Year Results
31st Oct 20187:00 amRNSNotice of Results
29th Oct 20187:00 amRNSNew Direct Investment in W2 Global Data Solutions
18th Oct 20187:00 amRNSCapital Markets Day
16th Oct 20187:00 amRNSNew Emerging Star investment into Locate Bio
21st Sep 201810:47 amRNSResult of AGM
21st Sep 20187:00 amRNSAGM Statement
18th Sep 20187:00 amRNSAston EyeTech secures multi-million pound contract
13th Sep 20187:00 amRNSNotice of Capital Markets Day
29th Aug 20187:00 amRNSGrant of Options
16th Aug 20187:00 amRNSnDreams secures multi-million dollar contract
7th Aug 20187:00 amRNSOG wins significant multi-million pound contract
27th Jul 20189:30 amRNSPublication of Annual Report
17th Jul 20183:14 pmRNSPDMR / Director Dealings
2nd Jul 20187:00 amRNSPreliminary Results
20th Jun 20187:00 amRNSVirtTrade secures partnership with Formula 1
12th Jun 20187:00 amRNSBoard Appointment
21st May 20187:00 amRNSNotice of Preliminary Results
17th Apr 20187:00 amRNSBoard Change
26th Mar 20187:00 amRNSDeferred Consideration and Board Change
22nd Mar 20187:00 amRNSNew Direct Investment in Voxpopme
2nd Mar 20187:00 amRNSSale of Science Warehouse Limited
1st Feb 20187:00 amRNSMercia Annual Gala Dinner
22nd Dec 20177:00 amRNSBoard Appointment
18th Dec 20177:00 amRNSAmendment to Share Options
13th Dec 20177:00 amRNS£5.0million syndicated investment into Intechnica
11th Dec 20177:00 amRNS£3.8million syndicated investment into Medherant
6th Dec 20177:00 amRNSHalf Year Results
24th Nov 20177:00 amRNSImpression Technologies secures grant funding
17th Nov 20177:00 amRNSNew Direct Investment in £5.0m syndicated round
14th Nov 20177:00 amRNSLife Sciences & Biosciences sector update
1st Nov 20177:00 amRNSNew Partnership with the University of Edinburgh

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.